|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Acadia Pharmaceuticals Inc., of San Diego, lowered the price range for shares to be sold in its initial public offering to $7 to $8, down from $12 to $14, apiece. The company, which is developing small-molecule drugs for central nervous system disorders, registered for its IPO more than two months ago. (See BioWorld Today, March 2, 2004.)
o AEterna Laboratories Inc., of Quebec City, said shareholders approved its new corporate name, AEterna Zentaris Inc. In conjunction, its Toronto Stock Exchange and Nasdaq ticker symbols will be changed in the near future to "AEZ" and "AEZS," respectively. The company's research and development efforts are focused on oncology ...